Parker et al. described that in cases of FAMMM, PC develops from normal duct epithelium to ductal hyperplasia to invasive ductal adenocarcinoma and suggested that patients with melanoma and CDKN2A mutation should be screened for pancreatic adenocarcinoma [72]. The gene discussed is CDKN2A; the disease is pachyonychia congenita.